M&A has been confined to smaller deals in Medicaid- and Medicare-focused companies.
By Dane Hamilton and Claire Rychlewski, with Mergermarket, an Acuris Company and partner of the M&A Leadership Council 

The U.S. health insurance market, roiled by transformative deals in recent years, will likely face a lull in major deal activity in 2020 while firms await critical federal election outcomes, industry executives said.